# OnCo record verona (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/verona/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "verona", "NCT04401748" ;
  schema:name "VERONA"@en ;
  schema:description "VERONA tested whether adding venetoclax to azacitidine, the combination that transformed treatment of acute myeloid leukaemia in older patients, would also help people with higher-risk myelodysplastic syndromes live longer; it did not meet that goal."@en ;
  schema:url <https://onco.cc/trials/verona/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04401748> ;
  onco:status "negative" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/mds-higher-risk/>, <https://onco.cc/cancers/mds/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/> ;
  onco:companies <https://onco.cc/companies/abbvie/> ;
  onco:people <https://onco.cc/people/amer-zeidan/> .
